Rights and permissions
About this article
Cite this article
Teva to terminate Promise trial after unfavourable interim analysis. Inpharma Wkly. 1364, 3 (2002). https://doi.org/10.2165/00128413-200213640-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213640-00004